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A B S T R A C T
Background
Breast cancer continues to be the most commonly diagnosed cancer in women globally. Early detection, diagnosis and treatment of
breast cancer are key to better outcomes. Since many women will discover a breast cancer symptom themselves, it is important that
they are breast cancer aware i.e. have the knowledge, skills and confidence to detect breast changes and present promptly to a healthcare
professional.
Objectives
To assess the effectiveness of interventions for raising breast cancer awareness in women.
Search methods
We searched the Cochrane Breast Cancer Group’s Specialised Register (searched 25 January 2016), Cochrane Central Register of
Controlled Trials (CENTRAL; 2015, Issue 12) in the Cochrane Library (searched 27 January 2016), MEDLINE OvidSP (2008 to
27 January 2016), Embase (Embase.com, 2008 to 27 January 2016), the World Health Organization’s International Clinical Trials
Registry Platform (ICTRP) search portal and ClinicalTrials.gov (searched 27 Feburary 2016). We also searched the reference lists of
identified articles and reviews and the grey literature for conference proceedings and published abstracts. No language restriction was
applied.
Selection criteria
Randomised controlled trials (RCTs) focusing on interventions for raising women’s breast cancer awareness i.e. knowledge of potential
breast cancer symptoms/changes and the confidence to look at and feel their breasts, using any means of delivery, i.e. one-to-one/group/
mass media campaign(s).
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Data collection and analysis
Two authors selected studies, independently extracted data and assessed risk of bias. We reported the odds ratio (OR) and 95%
confidence intervals (CIs) for dichotomous outcomes andmean difference (MD) and standard deviation (SD) for continuous outcomes.
Since it was not possible to combine data from included studies due to their heterogeneity, we present a narrative synthesis. We assessed
the quality of evidence using GRADE methods.
Main results
We included two RCTs involving 997 women: one RCT (867 women) randomised women to receive either a written booklet and
usual care (intervention group 1), a written booklet and usual care plus a verbal interaction with a radiographer or research psychologist
(intervention group 2) or usual care (control group); and the second RCT (130 women) randomised women to either an educational
programme (three sessions of 60 to 90 minutes) or no intervention (control group).
Knowledge of breast cancer symptoms
In the first study, knowledge of non-lump symptoms increased in intervention group 1 compared to the control group at two years
postintervention, but not significantly (OR 1.1, 95% CI 0.7 to 1.6; P = 0.66; 449 women; moderate-quality evidence). Similarly, at
two years postintervention, knowledge of symptoms increased in the intervention group 2 compared to the control group but not
significantly (OR 1.4, 95% CI 0.9 to 2.1; P = 0.11; 434 women; moderate-quality evidence). In the second study, women’s awareness
of breast cancer symptoms had increased one month post intervention in the educational group (MD 3.45, SD 5.11; 65 women; low-
quality evidence) compared to the control group (MD−0.68, SD 5.93; 65 women; P < 0.001), where there was a decrease in awareness.
Knowledge of age-related risk
In the first study, women’s knowledge of age-related risk of breast cancer increased, but not significantly, in intervention group 1
compared to control at two years postintervention (OR 1.8; 95% CI 0.9 to 3.5; P < 0.08; 447 women; moderate-quality evidence).
Women’s knowledge of risk increased significantly in intervention group 2 compared to control at two years postintervention (OR 4.8,
95% CI 2.6 to 9.0; P < 0.001; 431 women; moderate-quality evidence). In the second study, women’s perceived susceptibility (how
at risk they considered themselves) to breast cancer had increased significantly one month post intervention in the educational group
(MD 1.31, SD 3.57; 65 women; low-quality evidence) compared to the control group (MD −0.55, SD 3.31; 65 women; P = 0.005),
where a decrease in perceived susceptibility was noted.
Frequency of Breast Checking
In the first study, no significant change was noted for intervention group 1 compared to control at two years postintervention (OR 1.1,
95% CI 0.8 to 1.6; P = 0.54; 457 women; moderate-quality evidence). Monthly breast checking increased, but not significantly, in
intervention group 2 compared to control at two years postintervention (OR 1.3, 95% CI 0.9 to 1.9; P = 0.14; 445 women; moderate-
quality evidence). In the second study, women’s breast cancer preventive behaviours increased significantly one month post intervention
in the educational group (MD 1.21, SD 2.54; 65 women; low-quality evidence) compared to the control group (MD 0.15, SD 2.94;
65 women; P < 0.045).
Breast Cancer Awareness
Women’s overall breast cancer awareness did not change in intervention group 1 compared to control at two years postintervention
(OR 1.8, 95% CI 0.6 to 5.30; P = 0.32; 435 women; moderate-quality evidence) while overall awareness increased in the intervention
group 2 compared to control at two years postintervention (OR 8.1, 95% CI 2.7 to 25.0; P < 0.001; 420 women; moderate-quality
evidence). In the second study, there was a significant increase in scores on the Health Belief Model (that included the constructs of
awareness and perceived susceptibility) at one month postintervention in the educational group (mean 1.21, SD 2.54; 65 women)
compared to the control group (mean 0.15, SD 2.94; 65 women; P = 0.045).
Neither study reported outcomes relating to motivation to check their breasts, confidence to seek help, time from breast symptom
discovery to presentation to a healthcare professional, intentions to seek help, quality of life, adverse effects of the interventions, stages
of breast cancer, survival estimates or breast cancer mortality rates.
Authors’ conclusions
Based on the results of two RCTs, a brief intervention has the potential to increase women’s breast cancer awareness. However, findings
of this review should be interpreted with caution, as GRADE assessment identified moderate-quality evidence in only one of the two
studies reviewed. In addition, the included trials were heterogeneous in terms of the interventions, population studied and outcomes
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measured. Therefore, current evidence cannot be generalised to the wider context. Further studies including larger samples, validated
outcome measures and longitudinal approaches are warranted.
P L A I N L A N G U A G E S U M M A R Y
Interventions for raising breast cancer awareness in women
Review question
We reviewed the evidence about the effect of different interventions for raising breast cancer awareness in women. We found two
randomised controlled trials, the highest quality of research evidence.
Background
Breast cancer is the most commonly diagnosed cancer in women. Early detection, diagnosis and treatment of breast cancer are key to
better outcomes. Since many women will discover a breast symptom themselves, it is important that they are breast cancer aware i.e.
that they have the knowledge, skills and confidence to notice any breast changes and visit their doctor promptly.
Study characteristics
A search for trials investigating interventions on breast cancer awareness in women was run in January 2016. We found two trials with
a total of 997 women.
The Promoting Early Presentation (PEP) study, funded by Breast Cancer UK, involved randomising 867 women to receive one of three
interventions: (1) a written booklet and usual care, (2) a written booklet and usual care plus one-to-one discussion with a healthcare
professional or (3) usual care only. Women were aged between 67 to 70 years and recruited into the study at breast cancer screening
units in the UK.
The Zahedan University of Medical Sciences (ZUMS) study involved randomising 130 women into two groups that received either:
(1) an educational programme using written and oral materials that focused on “breast cancer preventive behaviours” (e.g. having a
healthy diet and positive beliefs towards breast self-examining behaviour) or (2) no intervention. Women were employed at ZUMS
and aged between 35 and 39 years.
Key outcomes
Study outcomes were measured differently in the two studies. The PEP study assessed outcomes at one month, one year and two years
after the intervention. The ZUMS study measured outcomes at one month after the intervention. Since the studies were very different
in terms of the participants’ age, interventions, outcomes and time points measured, the results are reported separately.
Knowledge of breast cancer symptoms
In PEP: women’s knowledge of breast cancer symptoms seemed to somewhat improve after receiving either the written booklet or
written booklet plus verbal interaction. These results improved when compared to usual care at 2 years postintervention. In ZUMS:
women’s awareness of breast cancer symptoms increased one month after the educational programme.
Knowledge of age-related risk of breast cancer
In PEP: knowledge of age-related risk increased for women who had received a written booklet and interacted with a healthcare
professional compared to usual care at 2 years postintervention. For women who only received the booklet, there was less of a comparable
increase in knowledge. In ZUMS: this study only measured if women perceived themselves to be at risk of getting breast cancer. This
self-perception of risk did increase at one month following the intervention.
Self-reported breast checking
In PEP: women’s reported monthly breast checking increased, but not significantly, at 2 years postintervention compared to usual care.
In ZUMS: women’s reported “breast cancer preventive behaviours” increased one month after the intervention. Specifically, this refers
to their positive beliefs towards breast self-examining behaviour.
Overall breast cancer awareness
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In PEP: women’s breast cancer awareness overall did not change after receiving a booklet alone compared to usual care at 2 years after
the intervention. However, breast cancer awareness increased in women who had received a written booklet and interacted with a
healthcare professional. This behaviour change was in comparison to usual care at 2 years postintervention. In ZUMS: women’s “breast
cancer preventive behaviours” were reported to increase at one month.
None of the studies reported on other parts of breast awareness, the intention to seek help, quality of life, adverse effects of the
interventions, or breast cancer-related outcomes.
Quality of the evidence
The evidence was considered to be moderate quality in the PEP study and low quality in the ZUMS study. Neither study clearly defined
‘breast cancer awareness’. The lack of high quality studies limited our ability to draw conclusions. However, the PEP study results
suggest that combining written information and a one-to-one discussion had a long-term effect on increasing women’s breast cancer
awareness. In the future, studies should use larger samples and follow the women for a longer time.
B A C K G R O U N D
Description of the condition
Although death rates are declining (Siegal 2013), breast can-
cer continues to be the most commonly diagnosed cancer in
women globally (Bray 2012). According toWorld Health Organi-
zation (WHO)Global Health Estimates, worldwide over 508,000
women are estimated to have died in 2011 due to breast can-
cer (WHO 2014). Early diagnosis of breast cancer is linked to
more favourable outcomes and longer survival (Richards 1999a;
Richards 1999b). While screening mammography is effective in
detecting some breast cancers, accuracy is dependent on breast
density (Carney 2003). Additionally, many breast tumours are
initially detected by women themselves (not by mammographic
screening) (Cancer Research UK 2014). However, some women
postpone presenting to a healthcare professional (HCP) on find-
ing a breast symptoms for a variety of reasons, including fear of
a cancer diagnosis (O’Mahony 2011). In an attempt to develop
consistency in definitions and approaches used in early cancer-
diagnosis research, Weller 2012 developed the ’Aarhus checklist’
as a resource for researchers. In their paper outlining this check-
list, the “patient interval” is described as (i) the “time taken to
interpret bodily changes/symptoms” i.e. “appraisal interval” and
(ii) the “time taken to act upon those interpretations and seek
help” i.e. the “help-seeking interval” (Weller 2012). To date, in
relation to breast symptoms, this “patient interval” varies from one
month to threemonths or evenmore (Arndt 2002;Meechan 2002;
O’Mahony 2009; Jones 2010; O’Mahony 2011; Forbes 2012;
O’Mahony 2013). Postponement of help-seeking (previously re-
ferred to as ’delay’) is associated in particular with women’s lack
of knowledge of non-lump breast symptoms (e.g. nipple changes;
O’Mahony 2013). This is a worrying situation given the increased
emphasis on prompt presentation of breast symptoms and the as-
sociated link with better healthcare outcomes for women who are
diagnosed with breast cancer earlier in the disease trajectory.
Breast screening may be carried out in a number of ways includ-
ing breast self-examination (BSE), clinical breast examination and
screening mammography (MacBride 2012). Screening mammog-
raphy is described as “the most widely used and best available tool
for detecting breast cancer” (MacBride 2012). However, the effi-
cacy of screening programmes is dependent on women’s participa-
tion (Chan 2007). Sincemany women will present with a palpable
breast mass (MacBride 2012), it is important that they have the
knowledge, skills and confidence necessary to detect and seek help
for breast cancer symptoms.
BSE is described as “a regular, repetitive monthly palpation to a
rigorous set method performed by the woman at the same time
each month” (Thornton 2008), using a method that has been for-
mally taught to women (MacBride 2012). While BSE continues
to be advocated for early detection of breast symptoms (American
Cancer Society 2014), a Cochrane Review reported lack of evi-
dence to support the use of breast screening by BSE or clinical
examination of breasts by a HCP in improving breast cancer mor-
tality rates (Kösters 2003). Nonetheless, the review highlighted
the need for women to be able to identify breast changes and seek
prompt medical advice should they discover changes that may be
breast cancer. This is further reiterated by theWHO 2014 report,
which recommends BSE as a means of “raising awareness amongst
women at risk” of breast cancer. Additionally, the practice of BSE
is incorporated into some breast health awareness interventions
(Chan 2007; Kharboush 2011), and into breast health-promoting
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strategies (Byrne 2009). Alternatively, the term ’breast checking’
has been used as part of ameasure of breast cancer awareness where
women were asked to report on how frequently they checked their
breasts (Linsell 2009; Forbes 2011a; Forbes 2012).
Currently the term ’breast awareness’ is cited in relation to breast
cancer screening and early detection of breast cancer (National
Comprehensive Cancer Network 2013; NICE 2013; American
Cancer Society 2014; IARC 2014). Furthermore, a recent edi-
torial in The Breast Journal highlighted “a paradigm shift” from
BSE to breast awareness, advocating that breast awareness be-
come part of general breast health education (MacBride 2012).
Breast awareness involves women having confidence to ’look at
and feel’ their breasts so that they know what is normal for their
own body and what changes to look and feel for (Irish Cancer
Society 2013; National Comprehensive Cancer Network 2013;
NHS Breast Cancer Screening Programme 2013). In addition,
breast awareness requires that women have an understanding of
the implications of breast changes and consult with their health-
care provider promptly (MacBride 2012). Therefore, the concepts
of ’breast awareness’ and ’breast cancer awareness’ are inextricably
linked. In addition BSE and, more recently, breast checking are
referred to as the behavioural components of each.
Whilst breast awareness is frequently advocated, evidence suggests
that women generally are not breast aware (Kharboush 2011). Fur-
thermore, it is suggested that public education about cancer symp-
toms and the value of early detection could enhance early pre-
sentation and improve cancer outcomes (Robb 2009). Thus, the
need for HCPs to increase awareness of breast cancer symptoms in
women is crucial. In the United Kingdom, the Promoting Early
Presentation (PEP) intervention was developed providing older
women (who are at much higher risk of developing breast cancer)
with knowledge, skills, confidence and motivation to present early
with breast cancer symptoms (Linsell 2009; Forbes 2011a; Forbes
2012). However, due to the earlier median age of diagnosis for
breast cancer, compared with other major cancers, it is suggested
that women have a slightly higher probability of developing cancer
before age 60 years (Siegal 2011). Currently, in Ireland 50% of
women who are newly diagnosed with breast cancer are under 60
years of age (mean age of diagnosis is 59.6 years; National Cancer
Registry Ireland 2012). A recent American study concluded that
while age is not an independent predictor of delayed diagnosis of
breast cancer, further research is necessary to enhance symptom
recognition amongst women and healthcare providers (Partridge
2012). Thus, more women of all ages, in particular young women,
might present with breast cancer at an earlier stage. In addition,
the need to reduce the health and economic burden of a breast
cancer diagnosis in younger women (aged 20 to 49 years) in the
United States of America has recently been highlighted (Ekwueme
2014). Thus, increasing breast awareness in women is necessary if
these targets are to be met. A systematic review of interventions
to promote cancer awareness and early presentation found lim-
ited evidence of the effectiveness of such interventions (Austoker
2009). In addition, there is lack of evidence of the impact of in-
creased breast cancer awareness on early detection of breast cancer.
Therefore, a review to assess the effectiveness of interventions for
raising breast cancer awareness in women is warranted.
Description of the intervention
For this Cochrane Review, we considered any intervention de-
signed to raise awareness of breast cancer. We included the in-
terventions of information or education, or both, specific to: (i)
breast cancer (potential breast cancer symptoms/changes); and (ii)
breast awareness (i.e. women having the confidence to look at and
feel (palpate) their breasts so that they know what is normal for
their own body and what changes to look and feel for). We ex-
tracted details relating to: (i) the format (written, verbal, online);
(ii) timing (number of sessions; time between sessions and dura-
tion of follow-up period); (iii) method of delivery (one-to-one/
group/mass media campaign(s); (iv) content; and (v) theoretical
underpinnings of each intervention.
How the intervention might work
The development of complex health-related interventions requires
a clear theoretical basis (Campbell 2007; Craig 2008). Under-
standing of the theoretical perspectives underpinning such inter-
ventions is critical if their effectiveness and usefulness in practice
are to be evaluated (Michie 2012). Therefore, clarity surrounding
the factors linked to breast cancer awareness and initiation of be-
havioural change is critical in terms of designing interventions to
raise breast cancer awareness in women.
Currently, information and education relating to the promotion of
breast cancer awareness are either specifically targeted at ’high risk’
individuals who have a greater risk of developing breast cancer or
they may be directed towards women in general. However, there
is a need to develop more innovative strategies to promote breast
health awareness and early detection of breast cancer in women
(Byrne 2009). It is suggested that early diagnosis of breast cancer
(enhanced by raising women’s breast cancer awareness) could lead
to decreasedmorbidity ormortality rates, or both (Richards 2009).
Why it is important to do this review
Increasing women’s awareness of breast cancer symptoms aims to
increase the number of women who present early to a HCP with
symptoms. Early presentation to a HCP has the potential to in-
crease early detection of breast cancer resulting in early treatment
and enhanced survival rates for women (Richards 2009). Con-
versely, as highlighted by Kösters 2003, increased BSE may lead
to unnecessary anxiety, medical consultations and costly follow-
up screening procedures for women. It could be argued that in-
creasing breast cancer awareness could have similar effects. How-
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ever, the benefits of early detection and prompt presentation of
symptoms could outweigh these.
It is apparent that there has been no systematic review undertaken
on the effects of educational interventions for raising breast can-
cer awareness in women. Such a review would provide clarity in
relation to these interventions and on outcomes for women who
are subsequently diagnosed with breast cancer. Thus, a systematic
review to determine the impact of interventions for raising breast
cancer awareness in women would benefit HCPs globally in their
efforts to reduce the breast cancer burden through its early de-
tection (Bray 2012), diagnosis and treatment. Data from the re-
view will determine the impact of increased breast cancer aware-
ness on earlier detection, stage of cancer at diagnosis and survival
outcomes. This knowledge could help to direct future strategies
around the promotion of breast cancer awareness and contribute
to the global effort to reducemortality andmorbidity due to breast
cancer.
O B J E C T I V E S
To assess the effectiveness of interventions for raising breast cancer
awareness in women.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We searched for randomised controlled trials (RCTs) and clus-
ter RCTs of interventions for raising breast cancer awareness in
women. In addition, we considered non-randomised studies pro-
vided they had (i) a control group and (ii) pre- and post-test esti-
mate of the effectiveness of the intervention. Attentionwas given to
the description of levels of potential confounders (e.g. age, socioe-
conomic status, education level, ethnicity, family history of breast
cancer, previous benign disease) in the intervention and non-in-
tervention group within studies and whether or not researchers
adjusted for these.
Types of participants
Women (with orwithout a previous breast cancer diagnosis) specif-
ically recruited to receive an intervention to raise breast cancer
awareness were eligible for inclusion. We excluded interventions
aimed at raising breast cancer awareness amongst HCPs.
Types of interventions
Group or individual educational interventions specifically focus-
ing on raising breast cancer awareness in women were eligible for
inclusion. Interventions promoting breast cancer awareness for
women through the provision of information on (i) breast cancer
symptoms and (ii) breast awareness (i.e. women having the confi-
dence to look at and feel (palpate) their breasts so that they know
what is normal for their own body and what changes to look and
feel for) were sought (Linsell 2009; Forbes 2011a; Forbes 2012).
Intervention in any setting (i.e. clinical/online/community) and
involving one single session or a number of sessions were consid-
ered. Interventions provided in a combination of various formats
including written brochures, video/audio tape, online or media
campaigns, were sought.
We excluded studies in which the intervention formed part of a
multi-component intervention in order to avoid confounding ef-
fects (i.e. interventions associated with knowledge of other can-
cers, other chronic illnesses and general lifestyle behaviours). We
excluded interventions promoting uptake of breast cancer screen-
ing or BSE, exclusively.
Standard care or no intervention was eligible as the comparator.
Types of outcome measures
Primary outcomes
1. Women’s knowledge of breast cancer symptoms. This was
based on patient-reported knowledge and awareness scores from
validated scales e.g. Breast Cancer Awareness Measure: BCAM
(Linsell 2010). In addition, we used other measures of knowledge
or awareness where reported e.g. knowledge of age-related risk.
2. Measure of confidence to check breasts i.e. engagement in
self-care behaviours relating to breast awareness (i.e. women
looking at and feeling/palpating their breasts so that they know
what is normal for their own body and what changes to look and
feel for). This was apparent in data reported by women relating
to their engagement in these self-care behaviours i.e. frequency of
breast checking at specific time frames.
3. Measure of breast cancer awareness overall (where available).
4. Measures of women’s motivation to check their breasts, as
outlined above (where available).
5. Measures of confidence to seek help when breast cancer
symptoms were noticed (where available).
6. Measure of time from breast cancer symptom being noticed
to presentation to a HCP (time-to-event data) indicating
postponed or prompt help-seeking behaviour (where available).
7. Measure of women’s intentions to seek help in the event of
noticing a breast cancer symptom and their perceptions of
barriers to help-seeking (where available).
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Secondary outcomes
1. Quality of life (classified by scales used by the trial authors)
or any measure of health status (i.e. physical, psychological,
social, spiritual, existential).
2. Adverse effects of receiving the intervention on breast
cancer awareness or adverse outcomes related to false positive
findings of symptoms (such as increased anxiety) assessed by any
validated self-report scale, or both.
3. Stage of breast cancer at diagnosis i.e. tumour, node,
metastases status (where reported).
4. Survival estimates: i.e. measured either from time of
intervention or time of breast cancer diagnosis (where reported).
5. Breast cancer-specific mortality and all-cause mortality
(where reported).
Main outcomes for assessing the quality of the evidence
Two review authors (MOM and JH) independently assessed the
quality of the evidence using the GRADE approach as outlined
in Chapter 12 of the Cochrane Handbook for Systematic Reviews
of Interventions (Schünemann 2011), and on the GRADE web-
site (http://www.gradeworkinggroup.org/).We assigned ratings of
’high’, ’moderate’, ’low’ or ’very low’ to each of the following pri-
mary outcomes: knowledge of breast cancer symptoms, knowl-
edge of age-related risk, frequency of breast checking and breast
cancer awareness. The quality of the evidence for adverse events
or secondary outcomes was not assessed as these were not reported
in the studies reviewed.
Search methods for identification of studies
Electronic searches
We searched the following databases:
1. The Cochrane Breast Cancer Group’s (CBCG’s) Specialised
Register (searched 25 January 2016). Details of search strategies
used by the CBCG for the identification of studies and
procedures to code references are outlined in the CBCG’s
module (http://onlinelibrary.wiley.com/o/cochrane/clabout/
articles/BREASTCA/frame.html). We extracted studies coded
with the key words “breast cancer”, “breast cancer awareness”,
“breast awareness”, “health education”, “health promotion”,
“educational program”, and “educational intervention” and
considered those studies for inclusion.
2. Cochrane Central Register of Controlled Trials
(CENTRAL; 2015, Issue 12) in the Cochrane Library (searched
27 January 2016). See Appendix 1.
3. MEDLINE OvidSP (2008 to 27 January 2016). See
Appendix 2.
4. Embase (Embase.com, 2008 to 27 January 2006). See
Appendix 3 and Appendix 4.
5. The WHO International Clinical Trials Registry Platform
(ICTRP) search portal (apps.who.int/trialsearch/Default.aspx)
for all prospectively registered and ongoing trials (searched 27
February 2016). See Appendix 5.
6. Clinicaltrials.gov (ClinicalTrials.gov) (searched 27 February
2016). See Appendix 6.
Searching other resources
Bibliographic searching
We sought further studies from reference lists of identified rele-
vant studies or reviews. A copy of the full article for each reference
reporting a potentially eligible study was obtained. Where this was
not possible, we attempted to contact trial authors for additional
information. We also performed a forwards citation search as ap-
propriate.
Grey literature
We checked relevant grey literature (i.e. unpublished data such as
reports, conference proceedings/abstracts, and doctoral theses) to
enable us to retrieve asmuch information as possible andminimise
the effects of publication bias (up to 22 March 2016).
Data collection and analysis
Selection of studies
Two review authors (MOM and JH) independently assessed the
titles and abstracts of each identified study for inclusion in the
review and examined compliance of identified studies with the
eligibility criteria. Following this initial evaluation, we retrieved
the full-text articles of all potentially relevant publications. We re-
solved any disagreements regarding eligibility of studies by con-
sulting a third author (MAC). Excluded studies were recorded
in the ’Characteristics of excluded studies’ section. We translated
studies reported in a language other than English, if necessary.
Data extraction and management
Two review authors (MOM and JH) extracted data from all rele-
vant studies using a data extraction form.
Information recorded included:
1. study details: author, date, country of origin;
2. participants: socio-demographics (age, socio-economic
status, education level, ethnicity); breast cancer history (previous
or family history, or both); number receiving intervention,
number receiving usual care;
3. methods: study aim, design, total study duration;
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4. intervention details: content, format, timing (already
outlined), method of delivery and theoretical underpinnings (if
any);
5. outcomes: extraction of all relevant findings related to
primary and secondary outcomes as specified previously;
6. withdrawals, length and method of follow-up and the
number of participants followed up;
7. miscellaneous issues.
Non-randomised studies were not identified. If identified in the
review update, we intend to record the following information.
1. Methods used to control for confounders.
2. Adjusted and unadjusted outcome measures.
For RCTs, we resolved any disagreements regarding extraction of
quantitative data by consulting a third author (MAC).Where nec-
essary, we sought additional data or information from the origi-
nal trial authors. Where we retrieved studies with more than one
publication, our decisions regarding which version to include de-
pended on its match with the inclusion criteria and relevance to
the overall aim of the review. One additional report was included
(Forbes 2011a relating to PEP).
Assessment of risk of bias in included studies
Two review authors (MOM and JH) independently assessed the
risk of bias of included studies using the Cochrane ’Risk of bias’
tool (Chapter 8 of Higgins 2011), the Cochrane EPOC Group’s
’Risk of bias’ criteria (Cochrane EPOC Group 2013) and Norris
2013. As the review did not include non-randomised studies, it
was not necessary to use guidance from Chapter 13 of Higgins
2011.
For assessing the risk of bias in RCTs, we considered the six bias
domains of: selection bias; performance bias; detection bias; attri-
tion bias; reporting bias; and other potential sources of bias. We
assigned each risk of bias domain a judgement of ’high’, ’low’ or
’unclear’ risk of bias. In the event of not reaching consensus, the
option of consulting a third review author (MAC) was available.
Where necessary, we contacted the original trial authors to seek
further clarification of methods used. We summarised the results
using both a ’Risk of bias’ graph and a ’Risk of bias’ summary. Key
questions addressing each bias criterion are outlined below.
Selection bias
Was the allocation sequence adequately generated?
We scored:
• ’low risk’ if a random component in the sequence
generation process is described (e.g. referring to a random
number table);
• ’high risk’ when a non-random method is used (e.g.
performed by date of admission);
• ’unclear risk’ if not specified in the paper (Cochrane EPOC
Group 2013).
Was the allocation adequately concealed?
We scored:
• ’low risk’ if participants and investigators enrolling
participants could not foresee assignment (e.g. a centralised
randomisation scheme, an on-site computer system or sealed
opaque envelopes were used) (Higgins 2011, Section 8.10;
Cochrane EPOC Group 2013);
• ’high risk’ if participants and investigators enrolling
participants could foresee assignment. Also non-randomised
studies should be scored ’high risk’;
• ’unclear risk’ if not specified in the paper (Higgins 2011,
Section 8.10; Cochrane EPOC Group 2013).
For future updates, if non-randomised studies are included,
we would consider the following questions:
Were baseline outcome measurements similar?
We will score:
• ’low risk’ if performance or patient outcomes were
measured prior to the intervention, and no important differences
were present across study groups;
• ’high risk’ if important differences were present and not
adjusted for in the analysis;
• ’unclear risk’ if not specified in the paper (Cochrane EPOC
Group 2013).
Were baseline characteristics similar?
• ’Low risk’ if baseline characteristics of the experimental and
control groups are reported and are similar.
• ’Unclear risk’ if it is not clear in the paper (e.g.
characteristics were mentioned in text but no data were
presented).
• ’High risk’ if there is no report of characteristics in text or
tables or if there are statistically significant differences between
control and intervention providers (Cochrane EPOC Group
2013).
Was there adequate adjusting for confounding?
• ’Low risk’ if appropriate methods were used to adjust for
confounding.
• ’Unclear risk’ if the methods used to adjust for confounding
were not reported.
• ’High risk’ if potential confounding from the following
variables were not addressed: age, socio-economic status,
education level, ethnicity, family history of breast cancer,
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previous benign disease (Higgins 2011, Section 13.5; Norris
2013).
Performance/detection bias
Was knowledge of the allocated interventions adequately
prevented during the study?
We scored:
• ’low risk’ if the trial authors state explicitly that the primary
outcome variables were assessed blindly or the outcomes are
objective, e.g. time-to-event data (prompt or delayed help-
seeking behaviour, i.e. presentation of breast symptoms to HCP);
• ’high risk’ if the outcomes were not assessed blindly;
• ’unclear risk’ if not specified in the paper (Cochrane EPOC
Group 2013).
Attrition bias
Were incomplete outcome data adequately addressed?
We scored:
• ’low risk’ if missing outcome measures were unlikely to bias
the results (e.g. reasons for missing outcome data are unlikely to
be related to true outcome, missing outcomes data are balanced
in numbers across intervention groups with similar reasons for
missing data across groups or missing data were imputed using
appropriate methods) (Higgins 2011, Section 8.13);
• ’high risk’ if missing outcome data was likely to bias the
results;
• ’unclear risk’ if it is not specified in the paper (Cochrane
EPOC Group 2013).
Reporting bias
Were reports of the study free from selective outcome
reporting?
We scored:
• ’low risk’ if there is no evidence that outcomes were
selectively reported (e.g. pre-specified outcomes are available in
the study protocol or all relevant outcomes in the methods
section are reported in the Results section);
• ’high risk’ if some pre-specified outcomes were
subsequently omitted from the results;
• ’unclear risk’ if not specified in the paper (Cochrane EPOC
Group 2013; Higgins 2011, Section 8.14).
Was the study free from selective analysis reporting?
We scored:
• ’low risk’ for each outcome if there is no evidence that
analyses were selectively reported (e.g. analyses were outlined in
the Methods section of the protocol or paper);
• ’high risk’ if there is evidence of selective analysis reporting
(e.g. multiple adjusted analyses have been carried out and only
one reported or ’extreme’ cut points have been used for creating
categorical outcomes);
• ’unclear’ if not specified in the paper (Cochrane EPOC
Group 2013; Norris 2013).
Measures of treatment effect
We intended using Review Manager 2014 to perform all analyses.
Final decisions regarding if and how to combine outcomes de-
pended onhowdatawere reported in the included studies.We con-
sulted Section 9.2 ’Types of data and effect measures’ of Higgins
2011 to guide our decisions.
We predicted that the data could be:
1. dichotomous (yes/no) (i.e. increased knowledge/awareness
of breast cancer symptoms; increased confidence to engage in
self-care behaviours relating to breast cancer awareness, such as
increased confidence or motivation to palpate breasts or
frequency of breast checking; increased breast cancer awareness
overall; increased confidence to seek help; increased intention to
seek help/time-to-event, such as early presentation of potential
breast cancer symptoms; mortality and presence of adverse effect
of the intervention);
2. continuous (e.g. changes in anxiety scales as a result of the
intervention and any of the pertinent outcomes, where reported
as such);
3. ordinal (e.g. tumour classification i.e. stage/size; categories
on a quality of life scale such as ’mild’, ’moderate’ or ’severe’);
4. nominal: perceptions of barriers to seeking help;
5. time-to-event: breast cancer-specific mortality and survival
estimates.
We estimated the effect measurement for dichotomous outcomes
using the odds ratio as the summary statistic. We planned to anal-
yse ordinal data either as continuous data (tumour classification
i.e. stage/size) or dichotomous data (cancer type: in situ yes/no or
invasive yes/no). In the case of quality of life, we planned to anal-
yse data as continuous or dichotomous depending on how trial
authors report data in the included studies. In this review, data on
tumour classification or quality-of-life data were not reported in
the included studies.
If appropriate, we planned to determine the effect measurement
for continuous data (changes in anxiety levels/decreased quality of
life/economic factors, and any of the pertinent outcomes, where
reported as such) using the mean difference (MD) and standard
deviation SD (when outcomes aremeasured using the same scales).
In the event of anxiety and quality of life being measured using
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different scales, we planned to calculate the standardised mean
difference (SMD), where appropriate. In this review version, in-
formation related to anxiety, quality of life and economic factors
were not reported in the included studies.
Time-to-event data were not reported in the included studies.
Therefore, in future review updates, if such data are available, we
plan to use hazard ratios as the summary statistic. We used 95%
confidence intervals (CIs) throughout the review.
Unit of analysis issues
Unit of analysis regarding women’s breast cancer awareness over
specific time frames have been categorised as short, medium and
long term i.e. six months, 12 months (PEP), and two years re-
spectively (Forbes 2011a). As far as possible, we identified periods
of follow-up (postintervention) in a similar fashion to reflect the
effects of interventions on raising breast cancer awareness within
short-term (≤ one-month), medium-term (≤ one-year) and long-
term (≤ two-year) time intervals.
Dealing with missing data
We sought information on missing data by contacting the trial
authors. One of the PEP trialists confirmed that missing data were
not imputed but a repeated measure analysis, which included all
women with a questionnaire from at least one time point, was
performed.Womenwithmissingdata at a particular time point did
not contribute to the point estimate at that time point. Attempts
to contact the ZUMS trialists were unsuccessful. Therefore, in this
review we presented the data narratively and discussed it in the
main text of the review.
Assessment of heterogeneity
Due to the diversity of outcomemeasures and associated reporting
in the included studies, an assessment of heterogeneity was not
performed. In future review updates, when reviewing comparable
outcome measures, we plan to assess inconsistency in study re-
sults i.e. statistical heterogeneity (due to clinical or methodologi-
cal diversity) by reviewing forest plots that display the study-spe-
cific estimates of our outcome measures along with the 95% CIs
where poor overlap of results indicates the presence of statistical
heterogeneity (Higgins 2011). We plan to quantify inconsistency
across studies using the I² statistic which describes “the percent-
age of variability in effect estimates that is due to heterogeneity
rather than sampling error (chance)” (Higgins 2011). It is sug-
gested that a result greater than 50% indicates substantial hetero-
geneity (Higgins 2011).
Assessment of reporting biases
As there were fewer than 10 included studies, we were unable to
formally assess reporting bias using funnel plots. In future review
updates, we will attempt to contact the trial authors to provide
information on missing data. Where this is not possible and we
suspect bias, we plan to determine the impact of including such
studies by testing for funnel plot asymmetry (as recommended in
Section 10.4.3.1 of Higgins 2011). We will include outcomes and
implications of results in the Discussion section, where appropri-
ate.
Data synthesis
As data were not combined in this review, in future review updates
we plan to present the data using Review Manager 2014. In the
current review version, three review authors (MOM, JH and TF)
extracted data, and reported the findings (as outlined in Higgins
2011).
In future review updates, we plan to use a random-effects model.
However, if we detect homogeneity across studies, we intend to use
a fixed-effect model for meta-analysis (Higgins 2011). Random-
effects pooled estimates are proposed as follows. For dichotomous
outcomes, we plan to pool odds ratios using the DerSimonian
and Laird random-effects method (DerSimonian 1986; Higgins
2011). Regarding continuous outcomes, we plan to pool data us-
ing the inverse variance random-effects method.We plan to obtain
pooled estimates of time-to-event outcomes using the random-ef-
fects inverse variance method.We propose that fixed-effect pooled
estimates will be obtained using the Mantel-Haenszel method for
dichotomous outcomes and inverse-variance method for contin-
uous outcomes. Regarding time-to-event data, we plan to use the
inverse variance method to pool estimates of the log(hazard ratio)
(Higgins 2011).
The GRADE approach
(outlined in Chapter 12 of the Cochrane Handbook for Systematic
Reviews of Interventions, Schünemann 2011, on the GRADE web-
site (http://www.gradeworkinggroup.org/) and in Ryan 2016) was
used to assess the quality of the evidence. We assigned ratings of
’high’, ’moderate’, ’low’ or ’very low’ to each of the following pri-
mary outcomes: breast cancer knowledge, age-related risk, breast-
checking behaviour and breast cancer awareness. This involved
two review authors (MOM and JH) independently assessing the
evidence for each outcome using five domains. These domains re-
late to: (i) risk of bias of the included studies (ii) inconsistency (i.e.
heterogeneity) (iii) indirectness (relevance to the review question)
(iv) imprecision (i.e. wide confidence intervals) and (v) publica-
tion bias. As it was not reasonable to pool estimates, we provided
a narrative account of the results of individual included studies.
We were unable to prepare a ’Summary of findings’ table using
GRADEpro software (as initially planned and as recommended in
Chapter 1 of Higgins 2011).
Subgroup analysis and investigation of heterogeneity
We proposed to perform subgroup analysis as necessary. It was
considered that this would involve analysis of subsets of partici-
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pants (determined by age groups; socio-economic factors; cultural
issues; previous history of breast cancer); study details (geograph-
ical location); mode of delivery of intervention (face-to-face/on-
line/one-to-one or group session); and time point at which the
outcome was assessed (i.e. ≤ one month or ≤ one year or ≤ two
years) postintervention. Due to a lack of included studies, small
sample size of one study (ZUMS) and homogeneity of samples in
both studies, subgroup analysis and investigation of heterogeneity
were not performed in this review.
Sensitivity analysis
Weproposed to perform sensitivity analysis to assess the robustness
of the review. Also, we planned to repeat the analysis excluding
studies of low methodological quality. The results of sensitivity
analyses were to be reported in a summary table. However owing
to the small number of studies included in this review, a sensitivity
analysis was not possible.
R E S U L T S
Description of studies
Results of the search
A total of 15,966 records were retrieved through a search of
databases in the original search. One additional study, Zeinomar
2013, was located using the ’forward citation’ function in Google
in which another potentially eligible study, Calderon 2010, was
cited. Another cross-reference, Williams 2013, was located within
one record reviewed (Ford 2014). Seven records were located from
the grey literature search. In total 10 additional records were re-
viewed; Figure 1.
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Figure 1. Study flow diagram.
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After exclusion of duplicates (n = 3099) and screening of remain-
ing records (12,885) by title or abstract, 39 full-text papers and
nine additional records were retrieved for evaluation. Two tri-
als in three publications (PEP: Linsell 2009 and Forbes 2011a;
ZUMS: Eskandari-Torbaghan 2014) met the inclusion criteria as
they related specifically to the promotion of breast cancer aware-
ness and three additional trials were deemed to be ’ongoing stud-
ies’ (NCT02205736; NCT01299623; IRCT201305068742N2).
Included studies
Two studies, PEP and ZUMS met the inclusion criteria as they
related specifically to the promotion of breast cancer awareness.
PEP was reported in two publications: Linsell 2009 and Forbes
2011a.
The Promoting Early Presentation (PEP) of breast cancer symp-
toms study investigated the efficacy of an intervention to equip
older women with the knowledge, skills, confidence and moti-
vation to detect breast cancer symptoms and seek help promptly
at one-month, one-year (Linsell 2009), and two-year time-points
(Forbes 2011a). The Zahedan University of Medical Sciences
(ZUMS) study sought to determine the effects of an educational
intervention on “breast cancer preventive behaviors” among fe-
male university medical staff, at one month postintervention.
Design
A total of 997 women were enrolled in the two RCTs (PEP;
ZUMS). PEP enrolled women from August 2007 to May 2008
and ZUMS enrolled female university medical staff in 2013.
Sample Size
PEP enrolled 867 women aged 67 to 70 years and ZUMS en-
rolled 130 younger women aged mean (standard deviation (SD))
35.38 years (8.01) (intervention group) and mean (SD) 34.39
years (8.98) (control group).
Setting
Women were recruited from seven breast screening units in Lon-
don and Surrey (PEP) and from among employees at Zahedan
University of Medical Sciences (ZUMS), in Iran.
Participants
PEP included women attending their final routine appointments
on the National Health Service (NHS) Breast Screening Pro-
gramme in the United Kingdom. ZUMS included a community
of women employed at Zahedan University of Medical Sciences.
Interventions
The PEP study used two types of interventions: (i) intervention 1
comprised a booklet conveying key breast cancer awareness mes-
sages, given by a radiographer to each woman who had received
her final routine mammogram, in addition to the usual care; (ii)
intervention 2 comprised a 10-minute one-to-one verbal interac-
tion with a radiographer or research psychologist plus booklet plus
usual care. The messages in the booklet were delivered in a posi-
tive, collaborative and motivational style, the booklet was referred
to throughout and given to the woman to take home. Photographs
of breast cancer signs were shown to the woman and breast check-
ing was demonstrated and rehearsed using a silicone breast. The
radiographer tailored the key messages by checking the woman’s
understanding and answering any questions.
The control group received the usual care i.e. the screening unit
receptionist informed each woman who had received her final
routine mammogram that she was no longer eligible for routine
screening but advised her that she might continue to be screened
every 3 years on request. The receptionist provided a card with
contact details and a suggested date for contact (PEP).
The ZUMS study examined the effects of an educational training
programme on the breast cancer preventive behaviours of female
employees of Zahedan University of Medical Sciences (ZUMS) in
Iran. The educational programme was based on the Health Belief
Model (i.e. perceived susceptibility, seriousness, benefits, barriers
and self-efficacy) and delivered by the researchers through lectures,
questions and answers, PowerPoint presentations, videos, an ed-
ucational booklet and compact disc (CD), over three 60- to 90-
minute sessions. The aim of the sessions was to increase women’s
awareness of breast cancer symptoms, their knowledge regarding
right time for mammography and to improve their practice of
“breast cancer preventive behaviours” (including physical activity,
healthy diet and positive beliefs towards breast self-examining be-
haviour, clinical examination and mammography).
The control group received no intervention.
Time points
Outcomes were measured at baseline, one month and one year
(Linsell 2009), and two years (Forbes 2011a); and pre- and one-
month post intervention (ZUMS). Different tests were used as
outcome measures in each study.
Both studies are described in further details in the ’Characteristics
of included studies’ table.
Ongoing trials
Three ongoing trials were identified from searches conducted on
theWHO ICTRP. One trial is almost complete as confirmed with
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the director of the study (NCT02205736). Another is ongoing and
recruitment is complete (IRCT201305068742N2), and recruit-
ment status of a third is unknown (NCT01299623). Attempts
to contact the principal investigators of the preceding three trials
were unsuccessful.
Excluded studies
We excluded 36 full-text publications (Reimer 2002; Pavic 2007;
Burgess 2008; Austoker 2009; Burgess 2009; Abd El Aziz 2009;
Calderon 2010; Forbes 2010a; Forbes 2010b; Forbes 2011b;
Kharboush 2011; Parsa 2011; Forbes 2012; Abuidris 2013;
Williams 2013; Zeinomar 2013; Anakwenze 2014; Ford 2014;
Forster 2014; Ginsburg 2014; Keating 2014; Khalili 2014; Liu
2014; Mena 2014; Wu 2014; Acikgoz 2015; Alipour 2015; Al
Khasawaneh 2015; Campbell 2015; Dey 2015; Duman 2015;
Gupta 2015; Hassan 2015; Livaudais-Toman 2015; Miller 2015;
Özmen 2015).
Reasons for exclusion were interventions focused on breast cancer
screening (Reimer 2002; Pavic 2007; Abuidris 2013; Khalili 2014;
Alipour 2015); one cross-sectional study on breast self-examina-
tion (BSE) (Parsa 2011); two interventions on BSE (Kharboush
2011; Miller 2015); one intervention study on BSE with no con-
trol group (Abd El Aziz 2009); a systematic review on interven-
tions for general cancer awareness (Austoker 2009); a literature re-
view on breast cancer awareness in Indian women (Gupta 2015); a
comparison studywith no control group (Calderon 2010); an edu-
cational intervention for breast cancer knowledge with no control
group (Zeinomar 2013); a one-group pre-survey and postsurvey
design study on breast cancer awareness and screening (Wu 2014);
nine cross-sectional surveys (Anakwenze 2014; Keating 2014; Liu
2014; Mena 2014; Acikgoz 2015; Al Khasawaneh 2015; Dey
2015; Duman 2015; Özmen 2015); one trial focusing on clinical
breast examination (CBE) and BSE (Hassan 2015); one RCT fo-
cusing on CBE (Ginsburg 2014); two studies with a mixed cancer
focus (Williams 2013; Ford 2014); and one intervention focusing
on awareness of personal risk of breast cancer (Livaudais-Toman
2015).
We excluded seven records associated with the PEP study on (i)
the development of the psycho-educational intervention (Burgess
2008), (ii) a qualitative study on the involvement of users in the de-
sign of the PEP intervention (Forbes 2010a), (iii) a conference ab-
stract of a paper describing the PEP intervention (Forbes 2010b),
(iv) a conference abstract of a paper on training the trainers (Forbes
2011b), (v) a first report of a national pilot of the PEP (Forbes
2012), (vi) an evaluation of further development of the PEP inter-
vention with no control group (Forster 2014), and (vii) promotion
of early presentation in older women in general practice with no
control group (Campbell 2015). Burgess 2009, a before-and-after
pilot study associated with the PEP study with no control group,
was also excluded (see Characteristics of excluded studies).
Five additional conference abstracts were identified and excluded
from the review as follows: Park 2011 (screening focused); Latha
2013 (no control group); Ersek 2014 (survey); Pakai 2014 (cross-
sectional survey); and Ferguson 2015 (mixed cancer focus). Also,
one report identified through the grey literature search, Eadie
2008, was excluded as it referred to an exploratory study to Guide
theDevelopment of a Pilot Breast Education and Awareness Cam-
paign.
Risk of bias in included studies
As this review included RCTs, two review authors (MOM and
JH) independently assessed the risk of bias of included studies
using theCochrane ’Risk of bias’ tool (Chapter 8 of Higgins 2011)
and the Cochrane EPOCGroup’s ’Risk of bias’ criteria (Cochrane
EPOCGroup 2013).The risk of bias in included studies has been
summarised in Figure 2.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study.
Allocation
Both studies used randomisation in assigning participants to the
intervention and control arms; however the methods used varied.
The PEP study was at low risk of bias for sequence generation
and allocation concealment. Sequence generation involved strat-
ified block randomisation (block sizes of three, six and nine) by
the radiographer and assignments were enclosed in sequentially
numbered, opaque, sealed envelopes and stored by the trial coor-
dinator before randomisation to ensure allocation concealment.
The risk of bias for random sequence generation and allocation
concealment in the ZUMS study was unclear as insufficient infor-
mation was provided in the publication and attempts to contact
the authors were unsuccessful.
Blinding
Blinding of participants and of personnel (performance bias) was
not addressed in the publications. However, this would have been
difficult to achieve due to the nature of the interventions in both
studies. Blinding of participants and personnel was rated as unclear
in the ZUMS study as insufficient information was available to
make a valid judgement.
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In the PEP study lack of blinding of participants and personnel
(radiographers) was confirmed with the authors, therefore the po-
tential for performance bias was rated as high.
Blinding of outcome assessment (detection bias) for the ZUMS
study was not addressed in the publication, therefore it was rated
as unclear. Communication with the authors of the PEP study
confirmed lack of blinding of outcome assessors, thus we rated
detection bias as high.
Incomplete outcome data
In PEP, women excluded from the targeted population and
women lost to follow-up were detailed with reasons and no at-
trition was reported. Thus, attrition bias was low. In ZUMS, no
women were excluded, lost to follow-up and no attrition was re-
ported. Therefore this study was at low risk of attrition bias.
Selective reporting
All relevant outcomes detailed in the methods sections were ade-
quately reported in the results section of PEP, therefore the study
was rated at low risk of reporting bias. However, detail on the
meaning of “breast cancer preventive behaviours” and how the
construct was measured were lacking in ZUMS, therefore it was
rated at unclear risk of bias for this domain.
Other potential sources of bias
Lack of clarity around the constructs of the Health Belief Model
in ZUMS puts it at unclear risk of bias. In addition, training of
the interventionists (i.e. the main investigators) and assessment of
adherence to the intervention protocol was not addressed. This
augmented the risk of bias in ZUMS.
Effects of interventions
Women’s knowledge of breast cancer symptoms
PEP study
PEP assessed women’s knowledge of the warning signs of breast
cancer froma list (n =11: two lump andnine non-lump) of possible
symptoms. To score one point, the woman had to identify at least
five non-lump symptoms, i.e. over half.
At one month postintervention, there appeared to be no difference
in the proportion of womenwhowere able to correctly identify five
or more non-lump symptoms in intervention group 1 compared
to the control group (OR 1.1, 95% CI 0.8 to 1.5; P = 0.61; 496
women). After onemonth post-intervention, there was an increase
in the proportion of womenwhowere correctly able to identify five
or more non-lump symptoms in intervention group 2 compared
to the control group (OR 2.5, 95% CI 1.7 to 3.6; P < 0.001; 488
women).
At one year postintervention, there was an increase in the propor-
tion of women who were correctly able to identify five or more
non-lump symptoms in intervention group 2 compared to the
control group (OR 1.7, 95%CI 1.1 to 2.4; P = 0.01; 463 women).
No difference was found at one year for intervention group 1 (OR
1.3, 95% CI 0.9 to 1.9; P = 0.23; 469 women).
At two years postintervention, knowledge of non-lump symptoms
increased in intervention group 1 compared to the control group,
but not significantly (OR 1.1, 95% CI 0.7 to 1.6; P = 0.66; 449
women). At two years postintervention, knowledge of non-lump
symptoms also increased in the intervention group 2 compared to
the control group but not significantly (OR 1.4, 95% CI 0.9 to
2.1; P = 0.11; 434 women).
Given that events are common for knowledge of breast cancer
symptoms PEP, misinterpretation of the OR as RR will overesti-
mate the intervention effect, as outlined in section 9.2.2.3. of the
CochraneHandbook for Systematic Reviews of Interventions (Higgins
2011).
ZUMS study
Awareness of breast cancer symptoms was measured using a 16
item-questionnaire and calculated results based on scores of 2 (cor-
rect answer), 1 (no comment) or 0 (incorrect answer) pre- and
one month post intervention ZUMS. Details of the questionnaire
were not provided and we were unable to contact the primary
author to clarify further. Regarding knowledge of breast cancer
symptoms, the construct of awareness was reported. An increase
in women’s awareness of breast cancer symptoms was detected one
month post intervention (mean difference (SD) 3.45 (5.11) in the
experimental group (65 women), compared to the control group,
where there was a decrease in awareness (mean difference (SD)
−0.68 (5.93) (65 women), P < 0.001).
Given the differentmeasures for this outcome, a meta-analysis was
not performed. In summary, in the PEP study women’s knowl-
edge of breast cancer symptoms increased significantly in the in-
tervention 2 group at one month and one year postintervention.
This effect was not sustained at two years. In the ZUMS study,
an increase in women’s awareness of breast cancer symptoms was
detected one month post intervention.
We downgraded the quality of the evidence for this outcome to
moderate in the PEP study (due to lack of blinding of participants,
personnel and outcome assessors) and limited sample (i.e. older
age group of women exiting the NHS screening programme in
London and South East England) and to low in the ZUMS study,
due to unclear risk of bias, limited sample (female employees in
one University of Medical Sciences in Iran) and small number of
events.
Women’s knowledge of age-related risk
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PEP study
Women were questioned on their knowledge of age-related risk
of getting breast cancer (i.e. that a 70-year-old woman was more
likely to get breast cancer compared to a 30-year-old or a 50-year-
old woman) and scored one point if they responded correctly.
At one month postintervention, the proportion of women who
knew that a 70-year-old woman was at most risk of breast cancer
increased in intervention group 1 compared to the control group
(OR 3.2, 95% CI 1.8 to 5.8; P < 0.001; 503 women). At one
month postintervention, the proportion of women who knew that
a 70-year-old woman was at most risk of breast cancer increased
in intervention group 2 compared to the control group (OR 9.5,
95% CI 5.1 to 17.6; P < 0.001; 499 women).
At one year postintervention, the proportion of women who knew
that a 70-year-old woman was at most risk of breast cancer in-
creased in intervention group 1 compared to the control group
(OR 3.4, 95% CI 1.8 to 6.7, P < 0.001; 471 women) and in in-
tervention group 2 compared to the control group (OR 7.4, 95%
CI 3.7 to 14.7; P < 0.001; 468 women).
At two years postintervention, the proportionofwomenwhoknew
that a 70-year-old woman was at most risk of breast cancer in-
creased in intervention 1 group (OR 1.8, 95% CI 0.9 to 3.5; P <
0.08; 447 women) though not significantly compared to the con-
trol groups. The proportion of women who knew that a 70-year-
old woman was at most risk of breast cancer increased significantly
in intervention group 2 (OR 4.8, 95% CI 2.6 to 9.0; P < 0.001;
431 women) compared to the control group.
ZUMS study
Age-related risk as such was not investigated in the ZUMS study.
Women’s attitude to their perceived susceptibility (i.e. women’s
considerations around their risk) of getting breast cancer was de-
termined by their responses to a six-item, five-option Likert scale
with scores for each item ranging from4 (totally agree) to 0 (totally
disagree).
An increase in women’s perceptions of their susceptibility to breast
cancer was detected onemonth post intervention (mean difference
(SD) 1.31 (3.57) in the experimental group (65women) compared
to the control group, where a decrease was noted (mean difference
(SD) −0.55 (3.31), 65 women), P = 0.005).
Given the differentmeasures for this outcome, a meta-analysis was
not performed. In summary, in the PEP study, women’s knowledge
of breast cancer risk increased significantly in both intervention 1
and 2 groups, at one month and one year. However, this increase
was only sustained at two years for intervention 2. In the ZUMS
study, women’s perceived susceptibility to breast cancer increased
significantly one month after the intervention.
We downgraded the quality of the evidence for this outcome to
moderate in the PEP study (due to lack of blinding of participants,
personnel and outcome assessors) and limited sample (i.e. older
age group of women exiting the NHS screening programme in
London and South East England) and to low in the ZUMS study,
due to unclear risk of bias, limited sample (female employees in
one University of Medical Sciences in Iran) and small number of
events.
Frequency of breast checking
PEP study
Women’s frequency of breast checking was measured in categories
ranging from “rarely or never”, “at least every 6 months”, “at least
once a month“ to “at least once a week”. A score of one point was
allocated if the woman reported checking her breasts either at least
once a month or at least once a week (PEP).
At baseline, almost half of the women reported checking their
breasts at least once amonth. At onemonth postintervention, there
was no effect on the breast checking behaviour of intervention
group 1 (booklet and usual care) compared to the control group
(OR 1.2, 95%CI 0.9 to 1.6; P = 0.25; 517 women). At onemonth
postintervention, the proportion of women checking their breasts
at least monthly increased in intervention group 2 (interaction
plus booklet and usual care) compared to the control group (OR
2.0, 95% CI 1.4 to 2.8; P < 0.001; 508 women).
At one year postintervention, the effects on intervention group 1
(OR 1.1, 95% CI 0.8 to 1.6; 482 women) and intervention group
2 (OR 1.3, 95% CI 0.9 to 1.8; 473 women) compared to the
control group were no longer significant (P = 0.47 and P = 0.23),
respectively.
At two years postintervention, the proportion of women checking
their breasts at least monthly increased in intervention group 1
compared to the control group (OR 1.1, 95% CI 0.8 to 1.6; 457
women), but not significantly (P = 0.54). At two years postinter-
vention, the proportion of women checking their breasts at least
monthly also increased in intervention group 2 compared to the
control group (OR 1.3, 95% CI 0.9 to 1.9; 445 women), but
not significantly (P = 0.14). An increase in breast checking from
53.3% at baseline (285 women) to 68.6% (229 women) following
the usual care was also reported in the control groups after two
years (Forbes 2011a).
Given that events are common for frequency of checking breasts
in the PEP study, misinterpretation of the OR as RR will overesti-
mate the intervention effect, as outlined in section 9.2.2.3. of the
CochraneHandbook for Systematic Reviews of Interventions (Higgins
2011).
ZUMS study
Women’s ”breast cancer preventive behaviours“ (which included
their positive beliefs towards breast self-examiningbehaviour)were
measured using a five-item, four-point Likert scale with scores
ranging from 3 (always) to 0 (never) (ZUMS).
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One month post intervention, women’s breast cancer preventive
behaviours increased in the experimental group (mean difference
(SD) 1.21 (2.54); 65 women) compared to the control group
(mean difference (SD) 0.15 (2.94); 65 women; P = 0.045).
Meta-analysis was not done for this outcome due to heterogeneity
of outcomes and outcomemeasures. In summary, in the PEP study
women’s frequency of breast checking increased significantly after
one month for intervention 2. In the ZUMS study women’s breast
cancer preventive behaviours increased significantly one month
post intervention.
We downgraded the quality of the evidence for this outcome to
moderate in the PEP study (due to lack of blinding of participants,
personnel and outcome assessors) and limited sample (i.e. older
age group of women exiting the NHS screening programme in
London and South East England) and to very low in the ZUMS
study, due to unclear risk of bias, limited sample (female employees
in one University of Medical Sciences in Iran), small number of
events and lack of clarity in the outcome being measured.
Breast cancer awareness
PEP study
The primary outcome of interest in the PEP study was the propor-
tion of women achieving breast cancer awareness at one, six and
12 months following intervention 1 and intervention 2 (Forbes
2011a). The breast cancer awareness score was a combination of
responses to the three questions from the trial-specific question-
naire, relating to: knowledge of symptoms, knowledge of age-re-
lated risk and reported breast checking.
At one month postintervention, the proportion of women who
were breast cancer aware increased in intervention group 1 com-
pared to the control group (OR 4.4, 95%CI 1.6 to 2.0; P = 0.004;
481 women). At one month postintervention, the proportion of
women who were breast cancer aware increased in intervention
group 2 compared to the control group (OR 24.0, 95% CI 7.7 to
73.7; P < 0.001; 473 women).
At one year postintervention, the proportion of women who were
breast cancer aware increased in intervention group 1 compared
to the control group (OR 3.5, 95% CI 1.2 to 10.5; P = 0.025; 456
women). At one year postintervention, the proportion of women
who were breast cancer aware increased in intervention group 2
compared to the control group (OR 15.2, 95% CI 4.8 to 47.8; P
< 0.001; 454 women).
At two years postintervention, the effects were not sustained in
intervention group 1 compared with the control group (OR 1.8,
95%CI 0.6 to 5.30; P = 0.32; 435women). At two years postinter-
vention, the proportion of women who were breast cancer aware
increased in intervention group 2 compared to the control group
(OR 8.1, 95% CI 2.7 to 25.0; P < 0.001; 420 women; Forbes
2011a).
ZUMS study
Breast cancer awareness per se was not reported in ZUMS.
Meta-analysis was not done due to variability of measurements
used. In summary, in the PEP study women’s breast cancer aware-
ness increased at one month and one year following interventions
1 and 2. At two years, only the effects of intervention 2 were sus-
tained.
We downgraded the quality of the evidence for this outcome to
moderate in the PEP study (due to lack of blinding of participants,
personnel and outcome assessors) and limited sample (i.e. older
age group of women exiting the NHS screening programme in
London and South East England).
Women’s motivation to check their breasts
This outcome was not assessed in either study.
Confidence to seek help when breast cancer
symptoms are noticed
This outcome was not assessed in either study.
Time from breast cancer symptom being noticed to
presentation to a HCP
This outcome was not assessed in either study.
Women’s intentions to seek help in the event of
noticing a breast cancer symptom and their
perceptions of barriers to help
This outcome was not assessed in either study.
Quality of life
This outcome was not assessed in either study.
Adverse effects of receiving the intervention on
breast cancer awareness or adverse outcomes related
to false positive findings of symptoms
This outcome was not assessed in either study.
Stage of breast cancer at diagnosis
This outcome was not assessed in either study.
Survival estimates
This outcome was not assessed in either study.
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Breast cancer-specific mortality and all-cause
mortality
This outcome was not assessed in the either study.
The quality of the evidence for adverse events or secondary out-
comes was not assessed as these were not reported in the included
studies.
D I S C U S S I O N
Summary of main results
We included two RCTs (PEP and ZUMS) involving 997 women
that investigated the effects of interventions on women’s breast
cancer awareness. A meta-analysis was not conducted as these
two studies used different measures for the primary outcomes of
women’s knowledge of breast cancer symptoms and age-related
risk and confidence to check their breasts. The PEP study aimed
at increasing women’s breast cancer awareness (i.e. knowledge of
breast cancer symptoms, knowledge of age-related risk and con-
fidence to check breasts) at one-month, one-year and two-year
time points. The researchers based their intervention on a theoret-
ical framework for delayed presentation of breast symptoms (Bish
2005). ZUMS sought to improve women’s ”breast cancer preven-
tive behaviours“ (including physical activity, healthy diet and pos-
itive beliefs towards breast self-examination, clinical examination
and mammography) one month post intervention, based on the
Health Belief Model.
Knowledge of breast cancer symptoms
In one study, PEP, women’s knowledge of breast cancer symp-
toms increased significantly at the one-month and one-year time
points, following a combination of usual care, booklet and one-
to-one verbal interaction (intervention 2). In ZUMS, an increase
in women’s awareness of breast cancer symptoms was detected one
month post a group training programme intervention.
Women’s knowledge of age-related risk
Usual care andbooklet (intervention1) and a combination of usual
care, booklet and one-to-one verbal interaction (intervention 2)
both caused a significant increase in women’s knowledge of breast
cancer risk at one month and one year in the PEP study. This
increase was only sustained at two years for intervention 2. In
ZUMS,women’s perceived susceptibility to breast cancer increased
significantly one month after a group training programme.
Frequency of breast checking
Women’s reportedmonthly breast checking increased significantly
following intervention2 at onemonth inPEP. InZUMS,women’s
”breast cancer preventive behaviours“ (which included their posi-
tive beliefs towards breast self-examining behaviour) had increased
significantly at one month postintervention.
Breast cancer awareness
The PEP study reported that women’s breast cancer awareness
increased at onemonth and one year following interventions 1 and
2. At two years, only the effects of intervention 2 were sustained.
Breast cancer awareness was not reported in the ZUMS study.
The two trials provide evidence that educatingwomen about breast
cancer using written material or a combination of written mate-
rial and a 10-minute interaction in one-to-one format or an in-
tervention of three 60- to 90-minute sessions, has potential to
increase women’s knowledge of breast cancer symptoms, knowl-
edge of age-related risks and frequency of breast checking. In one
study, a combination of these outcome measurements indicated
increased breast cancer awareness which was present at one year
following both types of intervention but was sustained at two years
only following the combination of booklet and one-to-one in-
teraction (PEP). Sustainment of outcomes (knowledge of breast
cancer symptoms, breast cancer susceptibility and breast cancer
preventive behaviours generally) for longer than one month was
not measured in the ZUMS study, which utilised three 60- to 90-
minute group presentations only.
The evidence provided from the review suggests that an educa-
tional intervention on breast cancer knowledge, using a combi-
nation of written material and verbal interaction in one-to-one
format, has potential to increase women’s breast cancer awareness,
over time. However, due to the limited number of studies, small
sample size in one study and heterogeneous nature of interven-
tions and outcomes measured, no conclusions can be drawn from
the review regarding the effects of interventions on breast can-
cer awareness. In addition, the term “breast cancer preventive be-
haviours” as used in the ZUMS study needs to be interpreted with
caution as although the practice of breast self-examination, clinical
examination and clinical mammography aim to detect early breast
cancer, they can never prevent breast cancer. Therefore, current
evidence cannot be generalised to the wider context.
Overall completeness and applicability of
evidence
The overall applicability of evidence is limited and incomplete.
This review identified only two RCTs that investigated the effec-
tiveness of two educational interventions on breast cancer aware-
ness. The overall outcome of breast cancer awareness i.e. women’s
knowledge of breast cancer symptoms/changes and confidence to
look and feel their breasts (i.e. breast checking and breast self-
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examining behaviour) to identify what is normal and know what
changes to look for, together with knowledge of breast cancer risk
factors (or perceived susceptibility to breast cancer) were evident
in both studies. However, the PEP study measured the outcome
of breast cancer awareness specifically whereas the ZUMS study
measured women’s ”breast cancer preventive behaviours“. Neither
study addressed time from noticing a breast cancer symptom to
presentation to aHCP; women’s intentions to seek help; quality of
life; adverse effect of the intervention; breast cancer-specific mor-
tality; and all-cause mortality. However, one preliminary evalua-
tive study, excluded from the current review due to absence of con-
trol group data, reported no significant increase in cancer worry
one month post intervention to promote breast cancer awareness
(Burgess 2009). Finally, interventions in the current review were
partly dependent on participants’ ability to comprehend the writ-
ten word. This limits transferability to individuals with lower lit-
eracy levels, visual impairment, learning or intellectual disabilities.
Quality of the evidence
Since the outcomes of interest were defined, measured and pre-
sented in different ways, it was not possible to present the quality of
the evidence for each outcome in a ’Summary of findings’ table. A
narrative account of the evidence within studies for each outcome
was presented. Overall, we rated the evidence in the PEP study to
be moderate quality with low risk of bias. We rated the ZUMS
study to be low quality with unclear risk of bias. Both studies are
heterogeneous in terms of the population, type of intervention,
content, timing and outcome measurements. Nonetheless, we are
moderately confident that a brief intervention can have a sustained
positive effect on some of the elements of breast cancer awareness
in older women. However, further trials with larger samples fo-
cusing on the key outcome measures associated with breast can-
cer awareness are warranted. While it must be acknowledged that
blinding would have been difficult to achieve for the type of inter-
vention under review, clear definition of the concept of interest is
necessary to guide future high-quality trials. Please refer to Figure
2 for a graphic representation of the methodological quality of
studies included.
Potential biases in the review process
The review was conducted in line with the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2011). We per-
formed a comprehensive, up-to-date search in the most relevant
databases. A methodological filter was not used, to ensure that no
studies would be missed. Nor did we use a language restriction.
The studies identified measured the first two primary outcomes of
interest to the review and findings were positive in both studies in
terms of increasing breast cancer awareness and breast cancer pre-
ventive behaviours, respectively. Although the number of studies
per outcome and intervention was too small to allow performance
of meta-analysis, a narrative account and assessment of the qual-
ity of the findings was presented. We corresponded with the au-
thors of both studies to clarify issues; these data were obtained for
PEP, which adds to the completeness of the review. On the other
hand, some additional information on the outcome measures in
the ZUMS study would have enhanced the review process.
An important limitation to the review is that it focused specifically
on the concept of breast cancer awareness, a concept that lacks
clarity in the literature. Initially much debate ensued over the topic
of interest i.e. breast awareness or breast cancer awareness, both
terms being interconnected as breast cancer awareness incorporates
breast awareness. We used part of the operational definition of
breast cancer awareness as outlined in the PEP study i.e. women’s
knowledge of breast cancer symptoms and confidence to check
breasts - their reported breast checking. Additionally, measure-
ment of age-related risk was also an aspect of breast cancer aware-
ness measured within the PEP study, which we did not include in
the protocol in order to broaden the focus of our search. However,
it is reported as an outcome in the review as it was specifically
reported in PEP and is inherent in the concept of susceptibility in
ZUMS. Similarly, the overall outcome of breast cancer awareness
is reported in the PEP study, and thus was considered important
to report in this review, although this was not outlined in the pro-
tocol. Furthermore, due to our focus on the broader construct of
breast cancer awareness, studies that reported knowledge of breast
cancer only or breast screening in isolation were excluded from the
review. However, this facilitated decisions around our inclusion
and exclusion of studies which was helpful given the number of
studies yielded from our searches of the databases. Subsequently,
more precision around types of studies to be included in the search
would enhance the review process.
Agreements and disagreements with other
studies or reviews
This review is the first systematic review on interventions for breast
cancer awareness in women. Only two trials, one large (n = 567)
UK-based study and one small (n = 130) Iranian study met the
inclusion criteria. A Cochrane Review on breast self-examination
included two large population-based studies (388,535 women)
from Russia (1999) and Shanghai (2002) (Kösters 2003, updated
in 2007). The first searched the Cochrane Breast Cancer Group
Specialised Register, the Cochrane Library and MEDLINE (Oc-
tober 2002). The updated review repeated this search and updated
the searches in the Cochrane Library and MEDLINE (PubMed)
in October 2007. This search yielded three RCTs, one of which
was excluded from analysis due to early termination of the study
(Philippines 2006). The final review found lack of evidence to
support the use of breast self-examination as a screening tool for
improving breast cancer mortality rates. Therefore, the promo-
tion of breast self-examination as a single screening method can-
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not be recommended. However, the review emphasised the need
for women to be able to identify breast changes and seek medical
advice promptly in the event of noticing a breast change. Sub-
sequently, there has been a paradigm shift from the concept of
breast self-examination to the broader concept of breast aware-
ness (MacBride 2012; National Comprehensive Cancer Network
2013; NICE 2013; American Cancer Society 2014; IARC 2014)
and breast cancer awareness (PEP), hence the focus of our review.
While our search identified a plethora of studies on interventions
promoting screening and breast self-examination, there is a paucity
of studies on interventions specifically for breast cancer awareness.
A systematic review was conducted in 2009 by Austoker and col-
leagues, on the effectiveness of interventions to increase cancer
awareness or promote early presentation (Austoker 2009). The
search strategy (the Cochrane Library, MEDLINE, Embase and
PsycINFO from 2000 to 2008) yielded five RCTs carried out in
the UK, United States and the Netherlands. One of the US stud-
ies, excluded from our review due to its focus on breast cancer
screening in women (n = 1091: aged 42 to 57 years), involved an
intensive intervention of tailored written information on breast
cancer risk, reinforced with a newsletter at 12 months and two
telephone counselling sessions (Reimer 2002). This intervention
increased the proportion of womenwho correctly answered a ques-
tion on age-related risk of breast cancer. While important, this
study focuses on only one aspect of knowledge related to breast
cancer awareness. Furthermore, the main aim of the intervention
was to promote breast cancer screening as opposed to breast cancer
awareness. The reviewers found limited evidence that interven-
tions lead to greater cancer awareness and earlier presentation in
the short term and concluded that further research is warranted on
the optimum interventions for long-term cancer awareness, which
was the focus of our review in relation to breast cancer (Austoker
2009).
A recent structured literature review (using Cochrane methodol-
ogy) on breast cancer awareness amongst women (n = 70: aged
15 to 70 years) in India, reported a search of the MEDLINE,
Cochrane Library, CINAHL and SCOPUS databases up to 2014,
yielding 13 eligible studies (Gupta 2015). The review reported
that awareness levels of risk factors for breast cancer were low
amongst Indian women (within 10 studies) and HCPs i.e. nurses
and students nurses (within three studies). The reviewers recom-
mend more intensive health-promoting intervention programmes
focusing on risk factors, prevention screening and management
of breast cancer. While this review highlights the importance of
women being knowledgeable about breast cancer risk, again it is
limited in that it focuses on only one aspect of breast cancer aware-
ness as opposed to a broader, more holistic definition of the con-
cept, as outlined by PEP.
Heterogeneity of terminology and outcomes being assessed in
these reviews makes it difficult to compare and contrast findings.
Nonetheless, what can be said is that researchers need to be clear
on the definitions of the concepts and outcomes being measured
in studies and reviews. To date, there appears to be much confu-
sion around the terms breast awareness, breast cancer awareness
and breast screening, all of which require clarification.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The aim of this review was to investigate the effectiveness of educa-
tional interventions on breast cancer awareness in women. How-
ever, the moderate quality of the evidence prevents any clear con-
clusions on the best design and content of an educational inter-
vention to increase breast cancer awareness in women. Nonethe-
less, the evidence from one study indicates that an educational in-
tervention on breast cancer symptoms, age-related risk and breast
checking behaviour, using a combination of written material and
a brief one-to-one interaction, has the potential to increase breast
cancer awareness in older women, over a sustained period of time.
Furthermore, the review highlights lack of clarity around terms
used in the literature in relation to breast awareness/breast cancer
awareness. If early detection and treatment of breast cancer is to
become a reality for women, clarity around these key concepts is
necessary. This is important for clinicians and policy makers who
are involved in the development and implementation of strategies
to promote breast cancer awareness.
Implications for research
In view of the low number of studies identified, heterogeneity
of interventions used, inconsistency in outcomes measured and
the overall moderate quality of the evidence available, further re-
search is necessary. Initial clarity around the concept of breast can-
cer awareness would facilitate the development of future inter-
ventions. Future high-quality trials are necessary to provide more
robust evidence on the effectiveness of such interventions for in-
creasing breast cancer awareness for women. Detailed description
of interventions, mode of delivery, measurement tools, time to fol-
low-up, outcome assessment and sustainability of the effect need
to be provided. Additionally, attention to the adverse effects of
the intervention will help identify whether further support might
be needed for women. Increased focus on the long-term effects
of interventions on women’s help-seeking, stage of diagnosis (if
relevant), quality of life and morbidity and mortality rates need to
be assessed in long-term RCTs. Broadening the scope of studies
to access the wider population of women is crucial. Literacy levels
and cost effectiveness will need to be considered also.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
PEP
Methods Accrual: August 2007 to May 2008
Muticentre (breast screening units n = 7); UK-based
Parallel group randomised controlled trial using stratified block randomisation (block
sizes of three, six and nine)
Follow-up: one month; one year
Participants Women aged 67 to 70 attending for final routine appointment on the UK NHS Breast
Screening programme
Interventions Intervention group 1 (n = 287): received a booklet conveying key breast cancer aware-
ness messages, given by a radiographer to each woman who had received her final routine
mammogram, in addition to the usual care
Intervention group 2 (n = 294): received a 10-min one-to-one verbal interaction with
a radiographer or research psychologist plus booklet plus usual care
Control group (n = 286): received the usual care (women were informed that they were
no longer eligible for routine screening, advised to continue to be screened every 3 years
on request and given a card with contact details and a suggested date for contact)
Outcomes Primary Outcomes
Knowledge of breast cancer symptoms, knowledge of age-related risk, confidence to
check breasts and overall breast cancer awareness
Breast cancer awareness
Women’s breast cancer awareness measured using a breast cancer awareness score (a
combination of responses to the three questions from the trial-specific questionnaire on:
knowledge of symptoms, knowledge of age-related risk and reported breast checking)
Notes Two-year follow-up reported by Forbes 2011a. Study funded by Cancer Research UK.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified block randomisation described.
Allocation concealment (selection bias) Low risk Detail on randomisation provided.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Lack of blinding of personnel & partici-
pants.
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Lack of blinding of outcome assessors.
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PEP (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Detail on attrition provided.
Selective reporting (reporting bias) Low risk All relevant outcomes detailed in Methods
section were reported in Results section
Other bias Low risk No other potential sources of bias were
identified.
ZUMS
Methods RCT
Accrual not specified
Convenient sample randomised into intervention or control group; randomisation
method not specified
Follow-up: one month
Participants Female employees of Zahedan University of Medical Sciences (ZUMS)
Mean (SD) age: Intervention group 35.38 (8.01); Control group: 34.39 (8.98)
Interventions Intervention group (n = 65)
An educational programme of three 60- to 90-min sessions delivered by the researchers
through lectures, questions and answers, PowerPoint presentations, videos, an educa-
tional booklet and compact disc (CD) to increase women’s breast cancer awareness. Ef-
fects were measured one month later
Control group (n = 65)
No intervention.
Outcomes Primary Outcomes
Women’s awareness of breast cancer symptoms and attitudes towards breast cancer (per-
ceived susceptibility, perceived seriousness, perceived benefits and barriers and self-effi-
cacy)
Secondary Outcomes
Breast cancer preventive behaviours (i.e. breast self-examining behaviour, clinical breast
examination, mammography and healthy diet)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Insufficient information provided to make
a valid judgement.
Allocation concealment (selection bias) Unclear risk Insufficient information provided to make
a valid judgement.
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ZUMS (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Insufficient information provided to make
a valid judgement.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Insufficient information provided to make
a valid judgement.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No women were excluded, lost to follow-
up and no attrition was reported
Selective reporting (reporting bias) Unclear risk Lack of information on the meaning of
breast cancer preventive behaviours and
how the construct was measured
Other bias Unclear risk (i) Lack of clarity around the constructs of
the Health Belief Model (ii) training of in-
terventionists and (iii) adherence to inter-
vention protocol
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Abd El Aziz 2009 Intervention study on BSE with no control group.
Abuidris 2013 A pilot study of an intervention focused on breast cancer screening
Acikgoz 2015 Cross-sectional study with no control group.
Al Khasawaneh 2015 Cross-sectional survey.
Alipour 2015 Breast cancer screening focused.
Anakwenze 2014 Cross-sectional survey.
Austoker 2009 A systematic review on interventions for general cancer awareness
Burgess 2008 PEP associated paper: describing the development of the psycho-educational intervention
Burgess 2009 PEP-associated paper: reports on a preliminary evaluation before and after study with no control group
Calderon 2010 Comparison study with no control group.
Campbell 2015 PEP-associated paper, promoting early presentation in older women in general practice, no control group
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(Continued)
Dey 2015 Cross-sectional survey.
Duman 2015 Cross-sectional survey.
Eadie 2008 Exploratory qualitative study.
Ersek 2014 Conference abstract: survey.
Ferguson 2015 Conference abstract: mixed cancer focus.
Forbes 2010a PEP-associated paper: qualitative study on the involvement of users in the design of the PEP intervention.
Forbes 2010b PEP-associated paper: promoting early symptomatic presentation in older women with breast cancer in the
NHS breast screening programme - conference abstract
Forbes 2011b PEP-associated paper: a report on training the trainers - conference abstract
Forbes 2012 PEP-associated paper: a first report of a National pilot of the PEP study.
Ford 2014 Mixed cancer focus: breast and cervical screening education.
Forster 2014 PEP-associated paper: evaluation of further development of PEP, no control group.
Ginsburg 2014 RCT focusing on adherence to clinical breast examination (CBE)
Gupta 2015 Literature review on breast cancer awareness in Indian women
Hassan 2015 RCT focusing on BSE and CBE.
Keating 2014 Cross-sectional survey.
Khalili 2014 Breast cancer screening focused.
Kharboush 2011 Intervention to increase practice of BSE.
Latha 2013 Quasi-experimental study, no control group - conference abstract
Liu 2014 Cross-sectional survey.
Livaudais-Toman 2015 Intervention focusing on awareness of risk of breast cancer.
Mena 2014 Cross-sectional survey.
Miller 2015 Cross-sectional study on BSE.
Pakai 2014 Cross-sectional survey - conference abstract.
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(Continued)
Park 2011 Conference abstract: based on screening mammography.
Parsa 2011 A cross-sectional study on knowledge related to BSE.
Pavic 2007 Intervention focused on breast cancer screening.
Reimer 2002 RCT on breast cancer screening.
Williams 2013 Mixed cancer focus: cervical and breast cancer.
Wu 2014 One-group pre-survey and post-survey design.
Zeinomar 2013 An educational intervention for breast cancer knowledge and screening behaviours with no control group
Özmen 2015 Cross-sectional survey on screening and breast cancer awareness
Characteristics of ongoing studies [ordered by study ID]
IRCT201305068742N2
Trial name or title The impact of education on preventive behavior of breast cancer
Methods Parallel-group, triple-blind, randomised controlled trial
Participants Women over age 30 who are not diagnosed with breast cancer
Interventions Intervention 1: intervention groups: face-to-face interviews and training (6 sessions) based on preventive
behaviour of breast cancer. Intervention 2: Control: face-to-face training (for moral reasons) will be provided
in 6 sessions on preventive behavior of breast cancer, post intervention 1
Outcomes Promotion of preventive breast cancer behaviour and awareness of breast cancer prevention; time frame: 3
months postintervention
Starting date 12 June 2013
Contact information khazaie m@yahoo.com
khazaee@razi.tums.ac.ir
Notes IRCT201305068742N2
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NCT01299623
Trial name or title Disseminating Breast Cancer Prevention to African American Women
Methods Parallel-group, double-blind, randomised controlled trial, 3- and 6-month follow-up, N = 200
Participants African American women, aged 35 to 70.
Interventions Active Comparator: Evidential Group Participants received education about breast cancer prevention and
specific information about African American women and breast cancer risk
Active Comparator: Non-Evidential Group Participants in this group received general information about
breast cancer prevention without anything specific to African American women
Outcomes Primary Outcome: women’s knowledge about breast cancer prevention; communication about breast cancer
prevention with HCP; the extent to which participants distrust medical research
Secondary Outcomes: assessment of the relationship between participants’ education and primary outcomes;
assessment of the relationship between participants’ family history and the primary outcomes; assessment of
the relationship between participants’ beliefs about research and the primary outcomes
Starting date 17 February 2011
Contact information Benita L Weathers, MPH weathers@mail.med.upenn.edu
Notes NCT01299623
NCT02205736
Trial name or title A Cross Sectional Study of a Breast Health Education Program for Under-served Latino Women in Union
and Mecklenburg County
Methods Intervention Model: Single Group Assignment, N = 250 approximately
Participants Latino women 18 years and over.
Interventions Small group breast health educational sessions for Latino women in home setting
Outcomes Change in baseline of breast cancer health literacy; time frame: one year
Starting date Registered on 20 July 2014
Contact information Daniel Carrizosa, MD, Carolinas Healthcare System, Levine Cancer Institute
Notes NCT02205736
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. CENTRAL
#1 MeSH descriptor: [Breast Neoplasms] explode all trees
#2 breast near cancer*
#3 breast near neoplasm*
#4 breast near carcinoma*
#5 breast near tumour*
#6 breast near tumor*
#7 #1 or #2 or #3 or #4 or #5 or #6
#8 breast cancer awareness or breast awareness
#9 breast near aware*
#10 MeSH descriptor: [Health Knowledge, Attitudes, Practice] explode all trees
#11 MeSH descriptor: [Health Education] explode all trees
#12 MeSH descriptor: [Health Promotion] explode all trees
#13 MeSH descriptor: [Awareness] explode all trees
#14 awareness or education or knowledge
#15 (promot* or educat* or knowledge or intervention* or inform* or aware*)
#16 educat* near intervention*
#17 #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16
#18 #7 and #17
Appendix 2. MEDLINE
1 Case-Control Studies/
2 Control Groups/
3 Matched-Pair Analysis/
4 Retrospective Studies/
5 ((case* adj5 control*) or (case adj3 comparison*) or control group*).ti,ab
6 or/1-5
7 Cohort Studies/
8 Longitudinal Studies/
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(Continued)
9 Follow-Up Studies/
10 Prospective Studies/
11 Retrospective Studies/
12 cohort.ti,ab.
13 longitudinal.ti,ab.
14 prospective.ti,ab.
15 retrospective.ti,ab.
16 or/7-15
17 randomized controlled trial.pt.
18 controlled clinical trial.pt.
19 randomized.ab.
20 placebo.ab.
21 Clinical Trials as Topic/
22 randomly.ab.
23 trial.ti.
24 (crossover or cross-over).tw.
25 Pragmatic Clinical Trials as Topic/
26 pragmatic clinical trial.pt.
27 or/17-26
28 exp Breast Neoplasms/
29 (breast adj6 cancer$).tw.
30 (breast adj6 neoplasm$).tw.
31 (breast adj6 carcinoma$).tw.
32 (breast adj6 tumo?r$).tw.
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(Continued)
33 or/28-32
34 breast cancer awareness.tw.
35 breast awareness.tw.
36 (breast adj5 aware*).tw.
37 awareness.tw.
38 Awareness/
39 Health Knowledge, Attitudes, Practice/
40 exp Health Education/
41 exp Health Promotion/
42 education.tw.
43 knowledge.tw.
44 (promot* or educat* or knowledge or intervention* or inform* or aware*).tw
45 (education* adj5 intervention*).tw.
46 Health Communication/
47 Patient Education as Topic/
48 or/34-47
49 and/33,48
50 animals/ not (humans/ and animals/)
51 49 not 50
52 and/6,51
53 and/16,51
54 and/27,51
55 limit 54 to yr=“2008 -Current”
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Appendix 3. Embase
#1 ’case control study’/syn OR ’case control study’ OR (’case control’ OR ’case base’ OR ’case matched’ OR retrospective)
NEXT/3 (analys* OR design* OR evaluation* OR research OR stud* OR survey* OR trial*)
#2 (cohort OR concurrent OR incidence OR longitudinal OR followup OR ’follow up’ OR prospective OR retrospective)
NEXT/1 (analys* OR design* OR evaluation* OR research OR stud* OR survey* OR trial*) OR ’prospective method’/
exp OR ’retrospective study’/syn
#3 random* OR factorial* OR crossover* OR crossNEXT/1 over* OR placebo* OR (doubl* AND blind*) OR (singl* AND
blind*) OR assign* OR allocat*OR volunteer* OR ’crossover procedure’/expOR ’crossover procedure’ OR ’double blind
procedure’/exp OR ’double blind procedure’ OR ’randomized controlled trial’/exp OR ’randomized controlled trial’ OR
’single blind procedure’/exp OR ’single blind procedure’
#4 ’breast’/exp OR ’breast disease’/exp AND ’neoplasm’/exp OR ’breast tumor’/exp OR (breast* NEAR/5 neoplas*):ab,ti
OR (breast* NEAR/5 cancer*):ab,ti OR (breast* NEAR/5 carcin*):ab,ti OR (breast* NEAR/5 tumo*):ab,ti OR (breast*
NEAR/5 metasta*):ab,ti OR (breast* NEAR/5 malig*):ab,ti
#5 ’breast cancer’/exp OR ’breast cancer’ OR ’breast neoplasm’OR ’breast carcinoma’/exp OR ’breast carcinoma’ OR ’breast
tumour’ OR ’breast tumor’/exp OR ’breast tumor’
#6 #4 OR #5
#7 ’breast cancer awareness’
#8 ’breast awareness’
#9 breast NEAR/5 aware*
#10 aware*
#11 ’health education’/exp OR ’health education’ OR health NEAR/5 education
#12 ’health promotion’/exp OR ’health promotion’ OR health NEAR/5 promotion
#13 ’awareness’/exp OR awareness
#14 ’education’/exp OR education
#15 ’knowledge’/exp OR knowledge
#16 (promot* OR inform* OR aware* OR educat* OR knowledge OR intervention*)
#17 educat* NEAR/5 intervention*
#18 #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17
#19 #6 AND #18
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(Continued)
#20 #19 AND [humans]/lim AND [embase]/lim
#21 #1 AND #20
#22 #2 AND #20
#23 #3 AND #20
#24 #23 AND [2008-2014]/py
Appendix 4. Embase (via Ovid SP)
1 Randomized controlled trial/
2 Controlled clinical study/
3 Random$.ti,ab.
4 randomization/
5 intermethod comparison/
6 placebo.ti,ab.
7 (compare or compared or comparison).ti.
8 ((evaluated or evaluate or evaluating or assessed or assess) and (compare or compared or comparing or comparison)).ab
9 (open adj label).ti,ab.
10 ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab
11 double blind procedure/
12 parallel group$1.ti,ab.
13 (crossover or cross over).ti,ab.
14 ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or partici-
pant$1)).ti,ab
15 (assigned or allocated).ti,ab.
16 (controlled adj7 (study or design or trial)).ti,ab.
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(Continued)
17 (volunteer or volunteers).ti,ab.
18 human experiment/
19 trial.ti.
20 or/1-19
21 exp case control study/
22 case control study.ti,ab.
23 ((case control or case base or case matched or retrospective) adj1 (analys* or design* or evaulation* or research or stud* or survey*
or trial*)).ti,ab
24 21 or 22 or 23
25 exp retrospective study/
26 exp prospective study/
27 ((cohort or concurrent or incidence or longitudinal or followup or ’follow up’ or prospective or retrospective) adj1 (analys* or
design* or evaluation* or research or stud* or survey* or trial*)).ti,ab
28 25 or 26 or 27
29 exp breast/
30 exp breast disease/
31 (29 or 30) and exp neoplasm/
32 exp breast tumor/
33 exp breast cancer/
34 exp breast carcinoma/
35 (breast$ adj5 (neoplas$ or cancer$ or carcin$ or tumo$ or metasta$ or malig$)).ti,ab
36 29 or 30 or 31 or 32 or 33 or 34 or 35
37 breast cancer awareness.tw.
38 breast awareness.tw.
39 (breast adj5 aware$).tw.
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(Continued)
40 aware$.tw.
41 exp health education/
42 (health adj5 education).tw.
43 exp health promotion/
44 (health adj5 promotion).tw.
45 exp awareness/ or awareness.tw.
46 exp education/ or education.tw.
47 exp knowledge/ or knowledge.tw.
48 (prmot$ or inform$ or aware$ or educat$ or knowledge or intervention$).tw
49 (educat$ adj5 intervention$).tw.
50 or/37-49
51 36 and 50
52 limit 51 to (human and embase and yr=“2014 -Current”)
53 20 and 52
54 24 and 52
55 28 and 52
Appendix 5. WHO ICTRP search portal
Basic searches:
1. Interventions for breast cancer awareness in women
2. breast cancer awareness AND intervention*
3. breast cancer AND education
4. breast cancer AND knowledge
5. breast cancer AND information
Advanced searches:
1. Title: Interventions for breast cancer awareness in women;
Recruitment Status: ALL
2. Title: breast cancer awareness;
Recruitment Status: ALL
3. Condition: breast cancer or breast cancer awareness;
Intervention: health promotion or health education or educational program* or educational intervention*;
Recruitment Status: ALL
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Appendix 6. Clinicaltrials.gov
Basic searches:
1. Interventions for breast cancer awareness in women
2. breast cancer awareness AND intervention*
3. breast cancer AND education
4. breast cancer AND knowledge
5. breast cancer AND information
Advanced searches:
1. Title: Interventions for breast cancer awareness in women
Recruitment: ALL
Study results: All studies
Study type: All studies
Gender: Studies with female participants
2. Title: breast cancer awareness
Recruitment: ALL
Study results: All studies
Study type: All studies
Gender: Studies with female participants
3. Condition: breast cancer or breast cancer awareness
Intervention: health promotion OR health education OR educational program* OR educational intervention*
Recruitment: ALL
Study results: All studies
Study type: All studies
Gender: Studies with female participants
C O N T R I B U T I O N S O F A U T H O R S
1. Drafted the protocol: MOM, JH, MGF
2. Study selection: MOM, JH
3. Extracted data from studies: MOM, JH
4. Entered data into RevMan: MOM
5. Carried out the analysis: MOM, JH, TF
6. Interpreted the analysis: MOM, JH, HC, TF, MAC, EAG
7. Drafted the final review: MOM, JH
8. Disagreement resolution: MAC
9. Updated the review: MOM
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D E C L A R A T I O N S O F I N T E R E S T
MOM: none known.
HC: none known.
TF: none known.
MAC: none known.
EF: none known.
EAG: none known.
MGF: none known.
JH: none known.
S O U R C E S O F S U P P O R T
Internal sources
• Professor Eileen Savage PhD Med BNS RGN RCN RM, Ireland.
Chair in Nursing & Head of School, and Colleagues in the Catherine McAuley School of Nursing and Midwifery, Brookfield Health
Sciences Complex, University College Cork, Ireland for their support in the completion of this review.
External sources
• Health Research Board, Ireland.
This review is funded by a Cochrane Fellowship awarded by the Health Research Board, Ireland
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Knowledge of age-related risk was added as a primary outcome as (i) it was a considered to be an important dimension of knowledge on
breast cancer and breast cancer awareness overall and (ii) was specifically reported in the PEP study as an outcome measure for breast
cancer awareness.
Confidence to check breasts was reported as frequency of breast checking in the PEP study, and as such within the current review.
Breast cancer awareness was added as (i) we had included the key dimensions of BCA i.e. knowledge of symptoms and confidence to
check breasts as outcomes to include in the review (ii) it was considered a central construct to the review and (iii) it was reported as the
primary outcome in the PEP study.
Other studies measuring breast cancer awareness would have been included provided they met the specific criteria for types of studies
to include in the review. Where studies were non-randomised, inclusion was dependent on (i) a control group and (ii) pre- and post-
test estimates of the effectiveness of the intervention.
Contribution of authors: MGF added to drafting of protocol.
Mark Corrigan details change to: Mark A Corrigan, Cork Breast Research Centre, Cork University Hospital, Cork, Ireland and Royal
College of Surgeons, Dublin, Ireland. He now reads as MAC in text.
Search for Embase (via OvidSP) added as access to Embase.com platform no longer available.
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